Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
American Tower
AMT
|
+$480M |
| 2 |
Canadian National Railway
CNI
|
+$364M |
| 3 |
Realty Income
O
|
+$249M |
| 4 |
VICI Properties
VICI
|
+$243M |
| 5 |
Enbridge
ENB
|
+$237M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$670M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 3 |
UnitedHealth
UNH
|
+$303M |
| 4 |
Prologis
PLD
|
+$239M |
| 5 |
Union Pacific
UNP
|
+$215M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 7.71% |
| 5 | Communication Services | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
ESAB
ESAB
$6.65B
| $214K | ﹤0.01% |
+4,877
| New | +$214K |
|
3002
Five Point Holdings
FPH
$448M
| $214K | ﹤0.01% |
54,682
-24,694
| -31% | -$96.6K |
|
3003
Global Industrial
GIC
$1.4B
| $214K | ﹤0.01% |
6,324
-878
| -12% | -$29.7K |
|
3004
Equity Bancshares
EQBK
$788M
| $212K | ﹤0.01% |
7,264
-75
| -1% | -$2.19K |
|
3005
REV Group
REVG
$2.89B
| $212K | ﹤0.01% |
19,506
-2,503
| -11% | -$27.2K |
|
3006
Arcturus Therapeutics
ARCT
$490M
| $210K | ﹤0.01% |
13,413
-10,535
| -44% | -$165K |
|
3007
Descartes Systems
DSGX
$8.59B
| $210K | ﹤0.01% |
3,387
-279
| -8% | -$17.3K |
|
3008
Esperion Therapeutics
ESPR
$548M
| $210K | ﹤0.01% |
33,030
+2,605
| +9% | +$16.6K |
|
3009
Nuvation Bio
NUVB
$1.12B
| $210K | ﹤0.01% |
64,886
-36,599
| -36% | -$118K |
|
|
IBDP
3010
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $210K | ﹤0.01% |
+8,487
| New | +$210K |
|
|
PTR
3011
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $210K | ﹤0.01% |
4,500
| – | – |
|
3012
Arrow Financial
AROW
$476M
| $209K | ﹤0.01% |
6,954
-1,002
| -13% | -$30.1K |
|
3013
Bionano Genomics
BNGO
$8.29M
| $209K | ﹤0.01% |
253
-52
| -17% | -$43K |
|
3014
EverQuote
EVER
$886M
| $209K | ﹤0.01% |
23,615
-77,603
| -77% | -$687K |
|
3015
National Presto Industries
NPK
$818M
| $209K | ﹤0.01% |
3,191
+341
| +12% | +$22.3K |
|
|
CDR
3016
DELISTED
Cedar Realty Trust, Inc
CDR
| $209K | ﹤0.01% |
7,257
+5,080
| +233% | +$146K |
|
3017
SPDR MSCI ACWI ex-US ETF
CWI
$2.13B
| $208K | ﹤0.01% |
8,736
| – | – |
|
3018
KRONOS Worldwide
KRO
$694M
| $208K | ﹤0.01% |
11,301
-876
| -7% | -$16.1K |
|
3019
ProShares Short S&P500
SH
$1.22B
| $208K | ﹤0.01% |
3,150
| – | – |
|
|
ME
3020
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $208K | ﹤0.01% |
+4,193
| New | +$208K |
|
|
DICE
3021
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $208K | ﹤0.01% |
13,424
+5,368
| +67% | +$83.2K |
|
3022
MeiraGTx Holdings
MGTX
$590M
| $207K | ﹤0.01% |
27,242
-5,084
| -16% | -$38.6K |
|
3023
Blend Labs
BLND
$1.1B
| $206K | ﹤0.01% |
+87,473
| New | +$206K |
|
3024
Microvast
MVST
$1.09B
| $206K | ﹤0.01% |
+92,597
| New | +$206K |
|
3025
Phibro Animal Health
PAHC
$1.56B
| $206K | ﹤0.01% |
10,810
-1,422
| -12% | -$27.1K |
|